Quantification of [<sup>11</sup>C]ABP688 Binding to mGluR5 in Human Brain using Cerebellum as Reference Region: Biological Interpretation and Limitations

The scarce availability of cerebellar allosteric binding sites at autoradiography, compared to immunohistochemistry results, might reflect the presence of distinct mGluR5 isoforms or conformational state. Together with our PET data, these data support the proposition that [<sup>11</sup>C]ABP688 BPND using the cerebellum as a reference region provides accurate quantification of mGluR5 allosteric binding in vivo. Studies relying on this method could, therefore, be used in clinical populations, providing that stronger initial assumptions are met.

Authors

Institutions

Publication Details

Journal
Current Neuropharmacology
Published
2025-02-20
DOI
https://doi.org/10.2174/1570159x23666250127161855
Citations
1
Primary Topic
Neuroscience and Neuropharmacology Research
Type
article
Field-Weighted Citation Impact
0.91

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Quantification of [11C]ABP688 Binding to mGluR5 in Human Brain using Cerebellum as Reference Region: Biological Interpretation and Limitations

José Eduardo Peixoto-Santos, Eliane Kobayashi, Luciano Minuzzi, Mark Angle et al.
1 citations
Current Neuropharmacology
Neuroscience and Neuropharmacology Research
0.91
article

Quantification of [11C]ABP688 Binding to mGluR5 in Human Brain using Cerebellum as Reference Region: Biological Interpretation and Limitations

José Eduardo Peixoto-Santos, Eliane Kobayashi, Luciano Minuzzi, Mark Angle, Jeroen Verhaeghe, Andrew J. Reader, Gassan Massarweh, Jean‐Paul Soucy, Michele Stanislaw Milella, Chawki Benkelfat, Marco Leyton, Esther Schirrmacher, Pedro Rosa‐Neto, Alexandre Kirlow, Marie‐Christine Guiot, Antonio Aliaga
article en
1 citations

Abstract

The scarce availability of cerebellar allosteric binding sites at autoradiography, compared to immunohistochemistry results, might reflect the presence of distinct mGluR5 isoforms or conformational state. Together with our PET data, these data support the proposition that [<sup>11</sup>C]ABP688 BPND using the cerebellum as a reference region provides accurate quantification of mGluR5 allosteric binding in vivo. Studies relying on this method could, therefore, be used in clinical populations, providing that stronger initial assumptions are met.

Current NeuropharmacologyVol. 23(9)
Montreal Neurological Institute and Hospital (CA), University of Antwerp (BE), University of Alberta (CA), King's College London (GB), Douglas Mental Health University Institute (CA), Policlinico Umberto I (IT), McGill University (CA), Sapienza University of Rome (IT), Universidade Federal de São Paulo (BR), McMaster University (CA)
Alzheimer's Association, Fondation Brain Canada, Government of Canada, Health Canada, Canadian Institutes of Health Research, Fonds de Recherche du Québec - Santé
Good health and well-being
Openalex Percentile: Top 30%
Neuroscience and Neuropharmacology Research
0.91
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.